First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?
Caterina Vivaldi, Francesca Salani, Giulia Rovesti, Irene Pecora, Silvia Catanese, Andrea Casadei‐Gardini, Valentina Massa, Laura Bernardini, Laura Riggi, Kalliopi Andrikou, Giovanni I. Rapposelli, Vincenzo Formica, Monica Lencioni, Alfredo Falcone, Enrico Vasile, Lorenzo Fornaro
Topics & Concepts
GemcitabineMedicineNab-paclitaxelInternal medicinePancreatic cancerGastroenterologyPopulationPaclitaxelChemotherapyToxicityOncologyCancerEnvironmental healthPancreatic and Hepatic Oncology ResearchRenal cell carcinoma treatmentCancer Cells and Metastasis